InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Novak Rodger, Président. Insider active across 1 company, notably CRISPR Therapeutics AG. Cumulatively, 6 reports have been logged. Split: 0 buy · 6 sells. Total volume traded: €13.8m. History available since 21 June 2021. The latest transaction was filed on 30 June 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations6 total
25,000 shares@ US$165.0025.3% of flowCommon SharesSEC:0001209191-21-044516
25,000 shares@ US$165.000.075% mcap25.3% of flowCommon SharesSEC:0001209191-21-044516:0
25,000 shares@ US$156.5523.8% of flowCommon SharesSEC:0001209191-21-044012
25,000 shares@ US$156.550.070% mcap23.8% of flowCommon SharesSEC:0001209191-21-044012:0
1,171 shares@ US$125.580.9% of flowCommon SharesSEC:0001209191-21-042811
1,171 shares@ US$125.580.0026% mcap0.9% of flowCommon SharesSEC:0001209191-21-042811:0
6 of 6 declarations
About Novak Rodger
Rodger Novak is the President of CRISPR Therapeutics AG. In this role, he oversees strategic operations and ensures growth and innovation. CRISPR Therapeutics AG is a biotechnology company specializing in genome editing. Rodger plays a key role in developing the company's vision and objectives.
